Amgen price target upped by Jefferies

Amgen Inc. was maintained by Jefferies & Co. analyst Adam Walsh at a buy rating but the price target was raised to $96 per share from $72 following second-quarter earnings. Jefferies also boosted its EPS estimates for 2005 to $3.20 from $2.91 and for 2006 to $3.75 from $3.37, given strong core product growth. Amgen shares Wednesday jumped $10.65, or 15.10%, to $81.17 on volume of 81,144,447 shares versus the three-month running average of 8,010,400 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.